Monogram Technologies Inc.

NasdaqCM:MGRM Stock Report

Market Cap: US$91.3m

Monogram Technologies Past Earnings Performance

Past criteria checks 0/6

Monogram Technologies's earnings have been declining at an average annual rate of -22.9%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 20.3% per year.

Key information

-22.9%

Earnings growth rate

-3.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate20.3%
Return on equity-90.3%
Net Margin-4,310.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?

Dec 04
Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?

Mar 21
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?

Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Deliver On Growth Plans?

Nov 17
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Deliver On Growth Plans?

Revenue & Expenses Breakdown

How Monogram Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:MGRM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-16710
30 Jun 240-12511
31 Mar 240-13611
31 Dec 230-14711
30 Sep 230-13710
30 Jun 230-1678
31 Mar 230-1346
31 Dec 220-1455
30 Sep 220-1455
30 Jun 220-1365
31 Mar 220-1475
31 Dec 211-1255
30 Sep 211-1045
30 Jun 211-934
31 Mar 210-934
31 Dec 200-925
30 Sep 200-824
30 Jun 200-633
31 Mar 200-422
31 Dec 190-210
30 Sep 190-110
30 Jun 190-110
31 Mar 190-110
31 Dec 180-110

Quality Earnings: MGRM is currently unprofitable.

Growing Profit Margin: MGRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MGRM is unprofitable, and losses have increased over the past 5 years at a rate of 22.9% per year.

Accelerating Growth: Unable to compare MGRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MGRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).


Return on Equity

High ROE: MGRM has a negative Return on Equity (-90.35%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:31
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Monogram Technologies Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason WittesRoth MKM
Thomas KerrZacks Small-Cap Research